Kunlong Zhang
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Case Report: Successful treatment of spondyloenchondrodysplasia with immune dysregulation using tofacitinib and ruxolitinib: a report of two pediatric cases.
Journal: Frontiers in pharmacology
Published: March 24, 2025
Immune deficiency due to SARS-CoV-2 infection in a child with GATA2-mutated AML: A case report.
Journal: Medicine
Published: January 22, 2025
FYB1-targeted modulation of CAPG promotes AML progression.
Journal: Molecular and cellular biochemistry
Published: November 11, 2023
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
Journal: Scientific reports
Published: August 31, 2023
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 18, 2023
Mycobacterium abscessus pulmonary disease presenting with spontaneous pneumomediastinum and subcutaneous emphysema in childhood acute lymphoblastic leukemia: a case report and literature review.
Journal: BMC pediatrics
Published: February 01, 2023
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1.
Journal: Journal of immunology research
Published: October 22, 2022
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.
Journal: Cell death & disease
Published: October 07, 2022
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes.
Journal: Cancer biology & therapy
Published: September 28, 2022
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.
Journal: Journal of immunology research
Published: May 07, 2022
Last Updated: 09/26/2026